Cargando…
Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain
Breakthrough pain is a newly recognized pain category that was first described by Portenoy and Hagen in 1990. The term describes pain that increases in intensity to “break through” chronic pain that is being controlled by a scheduled opioid regimen. The development of fluctuations in pain intensity...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393121/ https://www.ncbi.nlm.nih.gov/pubmed/22791984 http://dx.doi.org/10.2147/PPA.S20655 |